5^th World Congress on Virology December 07-09, 2015 Atlanta, USA

Virology 2015 welcomes attendees, presenters, and exhibitors from all over the world to Atlanta, USA. We are delighted to invite you all to attend and register for the “5th World Congress on Virology (Virology 2015)” which is going to be held during December 7-9, 2015 at Atlanta, USA.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Virology-2015, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Virology 2015 organizing committee look forward to meet you at Atlanta, USA.

Track 1: General Virology and Basic Science

The Americas commanded the most sizably voluminous share 42% of the Ecumenical Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.

Viral infections is one of the major cause of human and animal disease. Virus genomes are very small and they are incredibly diverse and subject to rapid genetic change. Viruses have their own ways of transmission. The mobility of animals increases the mechanisms of viral transmittance that have evolved, whereas plants remain immobile and thus viruses must rely on environmental factors to be transmitted between hosts.

Relevant Conferences:

5th World Congress on Virology December 07-09, 2015 Atlanta, USA;7th World Congress on Virology November 21-23, 2016 Baltimore, USA; 3rd International Conference on HIV/AIDS, STDs & STIs, Nov 30-Dec 02, 2015, Atlanta, USA;4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA; 2nd World Congress on Infectious Diseases August 25-27, 2016; 10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany;6th European Congress of Virology,Oct 19-22,2016 Germany; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina.

Track 2: Clinical and Neuro Virology

Clinical Trial Management System (CTMS) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019", states that the global clinical trial management systems market, which was worth US$844 million in 2013, will grow at a CAGR of 14% between 2013 and 2019 to acquire net worth of an estimated US$1,848.5 million by 2019.

Vector-borne diseases are infections transmitted by the bite of infected arthropod species, such as mosquitoes, ticks, sandflies, blackflies,etc. A blood-borne disease  is one that can be spread through contamination by blood and other body fluids. RNA silencing controls gene expression to regulate development, genome stability and anxiety incited reactions. In plants, RNA silencing is also recognized as a major immune system targeted against plant viruses.

Relevant Conferences:

7th World Congress on Virology November 21-23, 2016 Baltimore, USA; 3rd International Conference on HIV/AIDS, STDs & STIs, Nov 30-Dec 02, 2015, Atlanta, USA;4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA; 2nd World Congress on Infectious Diseases August 25-27, 2016; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada.

Track 3: Respiratory and Emerging/Re-emerging Viruses

As indicated by the U.S. Community for Disease Control and Prevention (CDC), Respiratory syncytial infection (RSV) is the basic reason for bronchiolitis or pneumonia in the youngsters under one year of age in the United States. Every year 75,000 to 125,000 kids are hospitalized because of RSV diseases.

An alphavirus belongs to the group IV Togaviridae family of viruses as per the arrangement of grouping taking into account viral genome organization presented by David Baltimore. Filoviruses belong to a virus family called Filoviridae and can cause severe hemorrhagic fever in humans and nonhuman primates. Picornaviruses are non-wrapped, positive-stranded RNA viruses with an icosahedral capsid. West Nile virus is a mosquito-borne zoonotic arbovirus belonging to the genus Flavivirus in the family Flaviviridae.

Relevant Conferences:

2nd International Conference on Influenza September 12-14 2016, Germany; 2nd World Congress on Infectious Diseases August 25-27 2016, USA; Annual Conference on H1N1 & Influenza Vaccines July 18-20 2016, USA; World Conference on Infection Prevention and Control August 1-2, 2016, Germany; 4th International Congress on Bacteriology and Infectious Diseases May 16-18 2016, USA; 5th Influenza Research & Development 2016,  USA;  Influenza Vaccines for the World October 6-9 October 2015, Portugal.World Veterinary Vaccine Congress November 9 - 11 2015, USA; Annual Influenza Update, September 17 2015, USA; Options IX for the Control of Influenza August 24-26 2016. 

Track 4: Agriculture and Plant Virology

The agricultural inoculants market, in terms of value is anticipated to reach $398.56 million by 2019, at a CAGR of around 9.5% from 2014.

The epidemiology of plant virus diseases concerns the cyclical development of virus diseases within plant populations in time and space. Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects a wide range of plants, especially tobacco and other members of the family Solanaceae. Mycology is the branch of science

which deals with the study of fungi, including their genetic and biochemical properties, their taxonomy and their use to humans as a source for tinder, medicine, wine and entheogens, as well as their dangers, such as poisoning or infection.

Relevant Conferences:

4th International Conference on Plant Genomics, July 14-15, 2016 Brisbane, Australia; Global Summit on Plant Science, September 21-23, 2015 San Antonio, USA; 5th International Conference on Agriculture and Horticulture, June 27-29, 2016 Cape Town, South Africa; International Conference on Plant Physiology, June 9-11, 2016 Dallas,USA; XIIIth International Plant Virus Epidemiology Symposium,June 6-10,2016 ,France; Australasian Plant Pathology Conference,September 14-16,2016 Fremantle, Western Australia; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada.

Track 5: Therapeutic Approaches and Targets for Viral Infections

The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.

DNA immunization is a novel method used to efficiently fortify humoral and cellular immune responses to protein antigens. Viral vaccines contain either inactivated viruses or constricted viruses .Inactive viral vaccines contain a virus, which have lost their ability to replicate and in order for it to bring about a response it contains more antigen than live immunizations. Allergy immunotherapy is a clinically documented efficacious treatment, which may considerably reduce the patient’s allergic symptoms and the need for traditional, symptom-relieving medication. Antiviral drugs are a class of medication utilized particularly for treating viral contaminations.

Relevant Conferences:

5th Global Microbiologists Annual Meeting August 15-17, 2016 Portland, USA;2nd World Congress On Beneficial Microbes,September 23-25, 2016 Phoenix, USA; International Conference on Infectious Diseases & Diagnostic Microbiology Oct 3-5, 2016 Vancouver, Canada;International Conference On Microbial Physiology And Genomics October 20-22, 2016 Rome, Italy; Microscopy Congress, 30th November - 1st December 2015, London, UK; New Approaches and Concepts in Clinical Microbiology,October 11 - 14, 2015, Heidelberg, Germany;19th International Conference on Recent Advances in Biomedical Science, January 9th, 2016, Kuala Lumpur, Malaysia; 3rd International Conference on Advances in Environment, Biomedical Sciences, January 12-13, 2016, Abu Dhabi,UAE.

Track 6: Veterinary Virology

The global animal healthcare market was esteemed at USD 27,861.2 million in 2013 and is expected to grow at a CAGR of 7.1% from 2014 to 2019, to achieve an expected estimation of USD 41,929.1 million in 2019.

Veterinary virology is the study of viruses in animals. It is an important branch of veterinary medicine. An emerging virus is a term applied to a newly discovered virus, one that is increasing in incidence or with the potential to increase in incidence. Zoonotic diseases/infections are those which can be naturally transmissible from vertebrate animals to humans. Prion disease represents a group of conditions that affect the nervous system in humans and animals.

Relevant Conferences:

7th World Congress on Virology November 21-23, 2016 Baltimore, USA; 3rd International Conference on HIV/AIDS, STDs & STIs, Nov 30-Dec 02, 2015, Atlanta, USA;4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA; 2nd World Congress on Infectious Diseases August 25-27, 2016; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada.

Track 7: Viral Immunology

The global infectious immunology market is forecast to reach $8.8 billion by 2017, growing at a compound annual growth rate (CAGR) of 6% during the period 2010-2017. The hepatitis infections fragment developed at 7% and was esteemed at $2 billion in 2010.

Cell signaling is part of a complex system of communication that administers basic cellular activities and coordinates cell activities. A Neutralizing antibody is an antibody which safeguards a cell from an antigen or infectious body by inhibiting or neutralizing any effect it has biologically. Cell-mediated immunity is an immune response that does not involve antibodies, but rather involves the activation of phagocytes, antigen-specific cytotoxic T-lymphocytes, and the release of various cytokines in response to an antigen.

Relevant Conferences:

2nd International Conference on Influenza September 12-14 2016, Germany; 2nd World Congress on Infectious Diseases August 25-27 2016, USA; Annual Conference on H1N1 & Influenza Vaccines July 18-20 2016, USA; World Conference on Infection Prevention and Control August 1-2, 2016, Germany; 4th International Congress on Bacteriology and Infectious Diseases May 16-18 2016, USA; 5th Influenza Research & Development 2016,  USA;  Influenza Vaccines for the World October 6-9 October 2015, Portugal.World

Veterinary Vaccine Congress November 9 - 11 2015, USA; Annual Influenza Update, September 17 2015, USA; Options IX for the Control of Influenza August 24-26 2016. 

Track 8: Viral Hepatitis

Due to the widespread infection of HCV and demand for these enhanced treatments, multiple estimates forecast the global market for HCV treatment will reach $20 billion yearly before the decade's get over.

Hepatitis is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis A is an intense irresistible infection of the liver caused by the hepatitis A virus. Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both intense and chronic infections. HCV is spread primarily by blood-to-blood contact connected with intravenous drug use, inadequately cleaned therapeutic gear, and transfusions.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th  International Conference and Exhibition on Pathology Conference, May 09-11, 2016,USA ; World Pathology Congress, June 16-18, 2016, Spain; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Latin and Ibero American Congress of Paediatric Gastroenterology, Hepatology and Nutrition, November 18-21, 2015, Lima, Peru; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France ; 12th Congress of E-AHPBA, May 23-26, 2017, Mainz, Germany; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA.

Track 9: HIV and Other Retroviral Diseases Affecting Afro-Asian Continents

The global HIV/AIDS market, including branded products and generics, was esteemed at $11.3 billion in 2010. This market is expected to reach $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 estimate period to reach $14.1 billion in 2016.

The human immunodeficiency virus is a lentivirus that causes HIV infection and AIDS.HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are research studies done to have a better approach, distinguish, or treat HIV/AIDS. Clinical trials are the fastest way to determine if new medical approaches to HIV/AIDS are safe and effective in people.

Relevant Conferences:

7th World Congress on Virology November 21-23, 2016 Baltimore, USA; 3rd International Conference on HIV/AIDS, STDs & STIs, Nov 30-Dec 02, 2015, Atlanta, USA;4th

International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA; 2nd World Congress on Infectious Diseases August 25-27, 2016; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada.

Track-10: Organ specific Cancer and Tumor virology

The global Cancer/Tumor Profiling Market was esteemed at $13.30 billion in 2012. At the end of 2013, the market is assessed to be $14.99 billion and is poised to reach around $35 billion by 2018, developing at a CAGR of 18.50% from 2013 to 2018.

Viral gastroenteritis is an inflammation of the stomach and intestines caused by one of any number of viruses. It is also known as the stomach flu. Hepatocellular carcinoma is the most common type of liver cancer. Most instances of HCC are secondary to either a viral hepatitis infection or cirrhosis. Simian virus 40,a polyomavirus that is found in both monkeys and humans. It was named for the impact it created on infected green monkey cells, which developed an unusual number of vacuoles.

Relevant Conferences:

2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA; International Conference on Infectious Diseases & Diagnostic Microbiology, October3-5, 2016; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia;4th International conference on Clinical Microbiology & Microbial Genomics, Oct 05-07, Philadelphia, USA; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada

Track 11: Regulatory and Economical Aspects in Virology

The vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%.

Major factors driving growth of vaccine technology market include rising prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans.

Relevant Conferences:

 2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA; International Conference on Infectious Diseases & Diagnostic Microbiology, October3-5, 2016; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia;4th International conference on Clinical Microbiology & Microbial Genomics, Oct 05-07, Philadelphia, USA; 32nd Clinical Virology Symposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium on NeuroVirology,2016, Canada

Track 12: Recent Advances in Drug Discovery

The worldwide business sector for drug discovery technologies and products reached $38.4 billion in 2011. It is expected to expand to $41.4 billion in 2012 and to $79.0 billion in 2017, a compound annual growth rate (CAGR) of 13.8% somewhere around 2012 and 2017. Another report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015.

 Drug-drug interactions occur when a drug interacts, or interferes, with another drug modify the way one or both of the drugs act in the body, or cause unexpected side effects. The drugs involved can be prescription medications, over-the-counter medicines and even vitamins and natural products.

Relevant Conferences:

Drug Discovery for Parasitic Diseases, January 24-28, 2016, USA; 7th International Conference on Drug Discovery and Therapy February 15-18, 2016, UAE; Structure Based Drug Design Conference, February 21–24, 2016, USA; 8th International Conference and Exhibition on Pharmaceutics and Novel Drug Delivery Systems March 07-09, 2016, Spain; 11th Annual Fragment-Based Drug Discovery, April 20-21, 2016, USA; Drug Discovery and Therapy World Congress May 11-14, 2016, USA; 4th Annual conferences on European Pharma Congress June 13-15, 2016, Germany; 9th World Drug Delivery Summit June 30-July 02, 2016, USA; 7th International conference and exhibition on Pharmacovigilance and Clinical Trials September 19-21, 2016, Austria; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016, Spain. 

Track 13: Current Focus in Virology Research

The global stem cell therapy market over the forecast period of 2015 to 2020. The business is ready to grow at a CAGR of 39.5% from 2015 to 2020, to achieve $330million by 2020.

Stem cell therapy is the utilization of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem cell therapy, but some therapies derived from umbilical cord blood are also in use. Clinical or medical virology is a branch of medicine which consists in isolating and/or in characterizing one or several viruses responsible for some human pathologies by various different immediate or circuitous systems.

Relevant Conferences:

6th World Congress on Cell & Stem Cells Research, Feb 29-Mar 2, 2016, Philadelphia, USA; 5th International Conference and Exhibition on Cell & Gene Therapy, May 19-21, 2016, San Antonio, USA; Annual Conference Stem Cell and Regenerative on Medicine, Aug 4-6, 2016, Frankfurt, Germany; 9th International Conference on Molecular & Cellular Cardiology, Aug 22-24, 2016, Sao Paulo, Brazil; 2nd International Conference and Exhibition on Tissue preservation and Bio-banking, Aug 18-19, 2016,  Portland, Oregon; Molecular and Cellular Basis of Growth and Regeneration, January 10-14, 2016 , Colorado, USA; Phacilitate Cell & Gene Therapy World, January 25-27, Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease, 1-3 February 2016, Dresden, Germany; Craniofacial Morphogenesis & Tissue Regeneration, March 13-18, 2016, California, USA; Keystone Stem Cells and Cancer, March 6-10, 2016 Colorado, USA.